芪苈强心胶囊联合重组人脑利钠肽治疗心力衰竭患者的临床疗效及其对心功能的影响-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

芪苈强心胶囊联合重组人脑利钠肽治疗心力衰竭患者的临床疗效及其对心功能的影响

Clinical efficacy of Qiliqiangxin capsule combined with recombinant human brain natriuretic peptidein the treatment of patients with heart failure and its influence on cardiac function

ES评分 0 浏览量：583 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20230358
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2023, 7(12)
作者	朱智慧*,
作者单位	河南大学第一附属医院河南开封 ;
摘要	分析心力衰竭患者运用芪苈强心胶囊联合重组人脑利钠肽治疗的临床疗效以及对其心功能的影响。方法随机筛选在我医院接受治疗的心力衰竭患者30例，运用随机数字表法分为观察组与对照组各有15例，对照组行重组人脑利钠肽治疗，观察组添加芪苈强心胶囊，对比两组治疗效果。结果治疗后，观察组患者的心功能改善效果明显优于对照组，患者的6分钟步行能力明显高于对照组，并发症发生率低于对照组，患者取得的治疗总有效率高于对照组，最终患者的生活活动能力和生活质量与对照组相比显著提高，（P＜0.05）。结论对心力衰竭患者及时开展芪苈强心胶囊联合重组人脑利钠肽治疗方案进行治疗，可使临床治疗效果得到进一步提升，减轻患者的心功能损伤程度，提高患者的生活活动能力以及生活质量。
Abstract	Objective To analyze the clinical effect of Qiliqiangxin capsule combined with recombinant human brain natriuretic peptide and its effect on its cardiac function. Methods 30 patients with heart failure treated in our hospital were randomly selected, and 15 cases were divided into observation group and control group with recombinant human brain natriuretic peptide, and the observation group added Qiliqiangxin capsule to compare the treatment effect of the two groups. Results After treatment, the improvement effect of cardiac function in the observation group was significantly better than that of the control group, the 6-minute walking ability was significantly higher than that of the control group, the complication rate was lower than that of the control group, the total response rate of the patients was higher than that of the control group, and the life activity and quality of life were significantly improved compared with that of the control group (P <0.05). Conclusion The timely treatment of Qiliqiangxin capsule combined with recombinant human brain natriuretic peptide for patients with heart failure can further improve the clinical treatment effect, reduce the degree of cardiac function damage of patients, and improve the life activity ability and quality of life of patients.
关键词	心力衰竭；芪苈强心胶囊；重组人脑利钠肽；心功能；效果分析
KeyWord	Heart failure; Qiliqiangxin capsule; Recombinant human brain natriuretic peptide; Heart function; Effect analysis
基金项目
页码	13-15

参考文献
相关文献

[1] 贾妍,张瑞宁,黄柳,等.冻干重组人脑利钠肽联合芪苈强心胶囊序贯治疗对急性失代偿性心力衰竭患者疗效及心功能的影响
[J].心脑血管病防治,2021,21(6):577-579,591.

[2] 董建.芪苈强心胶囊与重组人脑利钠肽联合治疗扩张型心肌病心力衰竭的疗效分析
[J]. 中国现代医生,2019, 57(34):109-112.

[3] 叶明,王鑫,孙悦,等.芪苈强心胶囊联合重组人脑利钠肽对急性心力衰竭患者的临床疗效观察
[J].中华内科杂志,2023,62(4):422-426.

[4] 杜玲.芪苈强心胶囊联合冻干重组人脑利钠肽对射血分数保留心力衰竭患者心功能分级及运动耐力的影响
[J].黑龙江医药科学,2022,45(3):156-157.

[5] 冯胜东,周芃.芪苈强心胶囊联合冻干重组人脑利钠肽对扩张型心肌病合并心力衰竭的疗效
[J].河南医学研究,2021,30(4):738-740.

[6] 阮静.芪苈强心胶囊联合冻干重组人脑利钠肽对HFPEF患者的影响
[J].黑龙江医药科学,2021,44(2):125-126.

[7] 郑伟维,张艳召,刘培乐.芪苈强心胶囊联合重组人脑利钠肽对扩张型心肌病心力衰竭患者心功能及日常生活能力的影响
[J].黑龙江中医药,2019,48(6):112-113.

[8] 刘玲,何野.芪苈强心胶囊联合西药治疗扩张型心肌病致心力衰竭的临床研究
[J].当代医学,2019,25(9):158-159.

[9] 李明春.重组人脑利钠肽联合芪苈强心胶囊对慢性心力衰竭患者心功能及血清NT-proBNP、cTnI水平的影响
[J].中国民康医学,2019,31(11):98-100.

[10] 董秋菊,王雄,乔占瑞.芪苈强心胶囊联合重组人脑利钠肽治疗射血分数中间值心力衰竭患者的临床观察
[J].中国药物与临床,2018,18(5):775-777.

引用本文

朱智慧*. 芪苈强心胶囊联合重组人脑利钠肽治疗心力衰竭患者的临床疗效及其对心功能的影响 [J]. 国际临床研究杂志. 2023; 7; (12). 13 - 15.

文献评论

相关学者

相关机构